» Articles » PMID: 31580968

3D Bioengineered Tissue Model of the Large Intestine to Study Inflammatory Bowel Disease

Overview
Journal Biomaterials
Date 2019 Oct 4
PMID 31580968
Citations 38
Authors
Affiliations
Soon will be listed here.
Abstract

An in vitro model of intestinal epithelium with an immune component was bioengineered to mimic immunologic responses seen in inflammatory bowel disease. While intestinal immune phenomena can be modeled in transwells and 2D culture systems, 3D tissue models improve physiological relevance by providing a 3D substrate which enable migration of macrophages towards the epithelium. An intestinal epithelial layer comprised of non-transformed human colon organoid cells and a subepithelial layer laden with monocyte-derived macrophages was bioengineered to mimic native intestinal mucosa cell organization using spongy biomaterial scaffolds. Confluent monolayers with microvilli, a mucus layer, and infiltration of macrophages to the basal side of the epithelium were observed. Inflammation, induced by E. coli O111:B4 lipopolysaccharide and interferon γ resulted in morphological changes to the epithelium, resulting in ball-like structures, decreased epithelial coverage, and increased migration of macrophages to the epithelium. Analysis of cytokines present in the inflamed tissue model demonstrated significantly upregulated secretion of pro-inflammatory cytokines that are often associated with active inflammatory bowel disease, including CXCL10, IL-1β, IL-6, MCP-2, and MIP-1β. The macrophage layer enhanced epithelial and biochemical responses to inflammatory insult, and this new tissue system may be useful to study and develop potential therapies for inflammatory bowel disease.

Citing Articles

Development and assessment of an intestinal tri-cellular model to investigate the pro/anti-inflammatory potential of digested foods.

Ramal-Sanchez M, Bravo-Trippetta C, DAntonio V, Corvaglia E, Kampfer A, Schins R Front Immunol. 2025; 16:1545261.

PMID: 39975553 PMC: 11835836. DOI: 10.3389/fimmu.2025.1545261.


The Use of Gut Organoids: To Study the Physiology and Disease of the Gut Microbiota.

Deng Y, Yuan X, Lu X, Wu J, Luo C, Zhang T J Cell Mol Med. 2025; 29(4):e70330.

PMID: 39968926 PMC: 11836903. DOI: 10.1111/jcmm.70330.


Multi-parametric Photoacoustic Imaging Combined with Acoustic Radiation Force Impulse Imaging for Applications in Tissue Engineering.

Nguyen C, Chen Y, Kaplan D, Mallidi S Ann Biomed Eng. 2024; 53(2):371-382.

PMID: 39294465 DOI: 10.1007/s10439-024-03617-7.


Development of an intestinal mucosa co-culture model to study viral infections.

Barreto-Duran E, Synowiec A, Szczepanski A, Galuszka-Bulaga A, Weglarczyk K, Baj-Krzyworzeka M J Virol. 2024; 98(10):e0098724.

PMID: 39212448 PMC: 11495016. DOI: 10.1128/jvi.00987-24.


In vitro co-culture models for studying organoids-macrophages interaction: the golden technology of cancer immunotherapy.

Liu J, Zhang B, Cui Y, Song H, Shang D Am J Cancer Res. 2024; 14(7):3222-3240.

PMID: 39113861 PMC: 11301299. DOI: 10.62347/BQFH7352.


References
1.
Peterson L, Artis D . Intestinal epithelial cells: regulators of barrier function and immune homeostasis. Nat Rev Immunol. 2014; 14(3):141-53. DOI: 10.1038/nri3608. View

2.
Lee S, Starkey P, Gordon S . Quantitative analysis of total macrophage content in adult mouse tissues. Immunochemical studies with monoclonal antibody F4/80. J Exp Med. 1985; 161(3):475-89. PMC: 2187577. DOI: 10.1084/jem.161.3.475. View

3.
Noel G, Baetz N, Staab J, Donowitz M, Kovbasnjuk O, Pasetti M . A primary human macrophage-enteroid co-culture model to investigate mucosal gut physiology and host-pathogen interactions. Sci Rep. 2017; 7:45270. PMC: 5366908. DOI: 10.1038/srep45270. View

4.
Hart P, Vitti G, Burgess D, Whitty G, Piccoli D, Hamilton J . Potential antiinflammatory effects of interleukin 4: suppression of human monocyte tumor necrosis factor alpha, interleukin 1, and prostaglandin E2. Proc Natl Acad Sci U S A. 1989; 86(10):3803-7. PMC: 287229. DOI: 10.1073/pnas.86.10.3803. View

5.
Neurath M . Cytokines in inflammatory bowel disease. Nat Rev Immunol. 2014; 14(5):329-42. DOI: 10.1038/nri3661. View